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Start- 21,439,648 base pairs from p arm terminus; end-
21,442,699 base pairs from p arm terminus; size- 3,051 
bases; orientation- minus strand. 
Protein 
Description 
273 amino acids; 30133 Da. NKX2-2 is a member of 
the NK2 family of homeobox transcription factors. It 
has known roles in the development of the CNS as well 
as pancreatic beta cell differentiation. In the CNS 
NKX2-2 is known to be activated by SHH signaling 
which is important for its initial role in ventral 
patterning. NKX2-2 expression has additionally been 
shown to be critical for the differentiation of 
oligodendrocytes, and in fact necessary for this process 
to occur. In both instances, NKX2-2 mediated  
transcripitional repression is both necessary and 
sufficient for these processes to occur. Regulation of 
NKX2-2 expression in the pancreas is less well 
understood. NKX2-2 knock-out mice die soon after 
birth from diabetic complications as a result of a lack of 
fully differentiated pancreatic beta cells. While NKX2-
2 mediated transcriptional repression has been 
demonstrated to be necessary and sufficient for its role 
in beta-cell differentiation, it remains unclear whet er 
NKX2-2 mediated transcriptional activation is 
important for NKX2-2 function in adult beta-cells. 
Expression 
V3 neural progenitors; oligodendrocyte precursor cells; 




NKX2-2 is a transcription factor. 
Homology 
NKX2-2 shares homology with other members of the 
NK2 family of transcription factors most notably in the 
TN transcriptional repression, DNA binding 
homeodomain, and specific domain regions. 
 
Schematic of NKX2-2 functional domains. The positions of the transcriptional repressor domain (TN), the homeodomain (HD), the NK2-
specific domain (SD), and the transcriptional activation domain (TAD) are shown. 
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Roughly 50% survival at 5 years for Ewing's sarcoma. 
Cytogenetics 
Ewing's sarcoma cells harbor the characteristic 
translocation t(11;22)(q24;q12) in roughly 90% of 
cases. 
Hybrid/Mutated Gene 
t(11;22)(q24;q12) fuses the 5' region of the EWSR1 
gene on chromosome 22 with the 3' portion of the FLI-
1 gene on chromosome 11. 
Abnormal Protein 
The translocation fusion product is termed EWS/FLI. 
Oncogenesis 
NKX2-2 is up-regulated in Ewing's sarcoma by the 
EWS/FLI translocation protein product. NKX2.2 
expression is necessary for the oncogenic phenotype of 
Ewing's sarcoma cells. 
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